Skip to main content
Dynavax Technologies Corporation (DVAX)
NASDAQ: DVAX · IEX Real-Time Price · USD
11.61
+0.13 (1.13%)
At close: Jul 26, 2024, 4:00 PM
11.42
-0.19 (-1.64%)
After-hours: Jul 26, 2024, 6:46 PM EDT

Dynavax Technologies Revenue

Dynavax Technologies had revenue of $50.79M in the quarter ending March 31, 2024, with 8.24% growth. This brings the company's revenue in the last twelve months to $236.15M, down -63.98% year-over-year. In the year 2023, Dynavax Technologies had annual revenue of $232.28M, down -67.86%.

Revenue (ttm)
$236.15M
Revenue Growth
-63.98%
P/S Ratio
6.44
Revenue / Employee
$578,797
Employees
408
Market Cap
1.52B

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 2023232.28M-490.40M-67.86%
Dec 31, 2022722.68M283.24M64.45%
Dec 31, 2021439.44M399.19M991.75%
Dec 31, 202040.25M5.03M14.29%
Dec 31, 201935.22M27.02M329.60%
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro
Dec 31, 2015 Pro Pro Pro
Dec 31, 2014 Pro Pro Pro
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Brookdale Senior Living 3.05B
Indivior 1.12B
U.S. Physical Therapy 611.97M
Phreesia 373.67M
Vir Biotechnology 79.60M
Nurix Therapeutics 62.30M
Revenue Rankings

DVAX News

More News